Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer

Abstract Tumor budding is defined as a single cell or a cluster of up to 5 tumor cells at the invasion front. Due to the difficulty of identifying patients at high risk for pT1 non-muscle-invasive bladder cancer (NMIBC) and the difficulties in T1 substaging, tumor budding was evaluated as a potentia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Markus Eckstein, Charlotte Kimmel, Johannes Bruendl, Florian Weber, Stefan Denzinger, Michael Gierth, Maximilian Burger, Arndt Hartmann, Wolfgang Otto, Johannes Breyer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ca635bbac05144efb1ac446a8f6dca4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ca635bbac05144efb1ac446a8f6dca4f
record_format dspace
spelling oai:doaj.org-article:ca635bbac05144efb1ac446a8f6dca4f2021-12-02T19:12:31ZTumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer10.1038/s41598-021-97500-32045-2322https://doaj.org/article/ca635bbac05144efb1ac446a8f6dca4f2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97500-3https://doaj.org/toc/2045-2322Abstract Tumor budding is defined as a single cell or a cluster of up to 5 tumor cells at the invasion front. Due to the difficulty of identifying patients at high risk for pT1 non-muscle-invasive bladder cancer (NMIBC) and the difficulties in T1 substaging, tumor budding was evaluated as a potential alternative and prognostic parameter in these patients. Tumor budding as well as growth pattern, invasion pattern and lamina propria infiltration were retrospectively evaluated in transurethral resection of the bladder (TURB) specimens from 92 patients with stage pT1 NMIBC. The presence of tumor budding correlated with multifocal tumors (p = 0.003), discontinuous invasion pattern (p = 0.039), discohesive growth pattern (p < 0.001) and extensive lamina propria invasion (p < 0.001). In Kaplan–Meier analysis, tumor budding was associated with significantly worse RFS (p = 0.005), PFS (p = 0.017) and CSS (p = 0.002). In patients who received BCG instillation therapy (n = 65), the absence of tumor budding was associated with improved RFS (p = 0.012), PFS (p = 0.011) and CSS (p = 0.022), with none of the patients suffering from progression or dying from the disease. Tumor budding is associated with a more aggressive and invasive stage of pT1 NMIBC and a worse outcome. This easy-to-assess parameter could help stratify patients into BCG therapy or early cystectomy treatment groups.Markus EcksteinCharlotte KimmelJohannes BruendlFlorian WeberStefan DenzingerMichael GierthMaximilian BurgerArndt HartmannWolfgang OttoJohannes BreyerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Markus Eckstein
Charlotte Kimmel
Johannes Bruendl
Florian Weber
Stefan Denzinger
Michael Gierth
Maximilian Burger
Arndt Hartmann
Wolfgang Otto
Johannes Breyer
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
description Abstract Tumor budding is defined as a single cell or a cluster of up to 5 tumor cells at the invasion front. Due to the difficulty of identifying patients at high risk for pT1 non-muscle-invasive bladder cancer (NMIBC) and the difficulties in T1 substaging, tumor budding was evaluated as a potential alternative and prognostic parameter in these patients. Tumor budding as well as growth pattern, invasion pattern and lamina propria infiltration were retrospectively evaluated in transurethral resection of the bladder (TURB) specimens from 92 patients with stage pT1 NMIBC. The presence of tumor budding correlated with multifocal tumors (p = 0.003), discontinuous invasion pattern (p = 0.039), discohesive growth pattern (p < 0.001) and extensive lamina propria invasion (p < 0.001). In Kaplan–Meier analysis, tumor budding was associated with significantly worse RFS (p = 0.005), PFS (p = 0.017) and CSS (p = 0.002). In patients who received BCG instillation therapy (n = 65), the absence of tumor budding was associated with improved RFS (p = 0.012), PFS (p = 0.011) and CSS (p = 0.022), with none of the patients suffering from progression or dying from the disease. Tumor budding is associated with a more aggressive and invasive stage of pT1 NMIBC and a worse outcome. This easy-to-assess parameter could help stratify patients into BCG therapy or early cystectomy treatment groups.
format article
author Markus Eckstein
Charlotte Kimmel
Johannes Bruendl
Florian Weber
Stefan Denzinger
Michael Gierth
Maximilian Burger
Arndt Hartmann
Wolfgang Otto
Johannes Breyer
author_facet Markus Eckstein
Charlotte Kimmel
Johannes Bruendl
Florian Weber
Stefan Denzinger
Michael Gierth
Maximilian Burger
Arndt Hartmann
Wolfgang Otto
Johannes Breyer
author_sort Markus Eckstein
title Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
title_short Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
title_full Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
title_fullStr Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
title_full_unstemmed Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
title_sort tumor budding correlates with tumor invasiveness and predicts worse survival in pt1 non-muscle-invasive bladder cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ca635bbac05144efb1ac446a8f6dca4f
work_keys_str_mv AT markuseckstein tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT charlottekimmel tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT johannesbruendl tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT florianweber tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT stefandenzinger tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT michaelgierth tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT maximilianburger tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT arndthartmann tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT wolfgangotto tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
AT johannesbreyer tumorbuddingcorrelateswithtumorinvasivenessandpredictsworsesurvivalinpt1nonmuscleinvasivebladdercancer
_version_ 1718377063398768640